+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Real World Evidence Solutions Market Size, Share & Trends Analysis Report by Component (Services, Data Sets), Application (Drug Development & Approvals), End-use, Therapeutic Area (Oncology, Cardiology), Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 150 Pages
  • May 2024
  • Region: Global
  • Grand View Research
  • ID: 5513884
Description Jump to:
The global real world evidence solutions market size is expected to reach USD 4.6 billion by 2030, registering a CAGR of 8.4% from 2024 to 2030. Key driving factors of the market include growing applications of RWE in several fields, favorable government regulations, technological advancements, and a shift from volume to value-based care. Furthermore, a growing number of strategic initiatives by organizations are anticipated to positively influence market growth.

In March 2024, DARWIN EU, the Data Analysis & Real World Interrogation Network, announced plans to enhance its capacity for RWD studies by adding 10 new data partners within the year. With a network of 20 institutions spanning 13 European countries, DARWIN EU collaborates with public & private entities to derive RWE from diverse sources, including hospitals, primary care facilities, health insurance databases, registries, and biobanks.

This RWE supports regulatory activities of the EMA and national regulators across the EU. Leveraging data from approximately 130 million patients across Europe, DARWIN EU aims to deliver robust evidence through RWD studies. Notably, the network employs a common data model to standardize data interpretation while ensuring data privacy through local storage and analysis by data partners. This approach prioritizes data protection and facilitates the efficient execution of large-scale, multi-database studies.

Furthermore, major consumers of RWE are pharmaceutical and medical device companies. This is because it can provide value across the entire product lifecycle. It has applications across life science research, clinical trials & studies, post-market surveillance, and regulatory requirements. In life science research, RWE can inform pretrial study design by assisting researchers in identifying potential patients and creating proper inclusion criteria for clinical trials. Within clinical trials & studies, it helps overcome traditional clinical trials’ limitations by providing information about a broader cross-section of society and supplementing traditional outcome measures, such as patient-reported outcome surveys.

Moreover, medical product designers are using RWD & RWE to aid clinical trial designing (e.g., pragmatic clinical trials, large simple trials) and observational studies to produce innovative, new treatment approaches. Thus, technology plays a significant role in healthcare decisions, which, in turn, promotes segment growth. For instance, in July 2023, Johnson & Johnson gained approval for certain cardiac ablation devices for fluoroscopy-free use following a prospective observational registry study-an instance of the agency employing RWE in device reviews.

In addition, several companies are focusing on RWD collection to enhance RWE in the neurology sector. For instance, in September 2023, OM1 announced a curated research-grade dataset focused on Parkinson's disease (PD) as part of its Mental Health and Neuroscience RWD Network expansion. This dataset features premium data from over 7,000 individuals with PD, tracked prospectively by neurologists, along with data from 700,000 PD patients in the OM1 Real-World Data Cloud. The RWE insights from this comprehensive data are anticipated to enhance understanding of PD patient journeys, leading to improved care & outcomes.

Real World Evidence Solutions Market Report Highlights

  • Based on component, the services segment led the market with the largest share of 57.7% in 2023 owing to its increasing demand over the forecast period
  • Based on application, the drug development and approvals segment dominated the market with a revenue share of 28.7% in 2023 owing to the rising adoption of RWE solutions in pharmaceutical companies for this application
  • Based on end-use, healthcare companies dominated the market with the largest share of 32.8% in 2023. The growth is due to growing use of RWE solutions in several fields by pharmaceutical, biopharmaceutical, and medical device companies
  • Based on therapeutic area, the oncology segment led the market with a share of 22.8% in 2023 owing to increased use of RWE solutions to develop therapies for cancer care by research organizations and pharmaceutical companies
  • North America led the global market with a revenue share of 43.5% in 2023 owing to the presence of major players in the region. Asia Pacific is expected to be the fastest-growing regional market from 2024 to 2030 owing to the presence of contract research organizations in the region

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates & Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Consensus-based Estimates & Forecasting
1.6.1.1 Commodity Flow Analysis
1.6.1.2 Top-down Market Estimation
1.6.1.3 Country-based Segment Share Calculation
1.6.2 Multivariate Analysis
1.6.3 Real World Evidence Solutions Market: Cagr Calculation
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective - 1
1.8.2 Objective - 2
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Real World Evidence (Rwe) Solutions Market Variables Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Favorable Government Regulations
3.2.1.2 Rising Applications of Real-world Evidence (RWE) in Various Fields
3.2.1.3 Technological Advancements
3.2.1.4 Increasing Initiatives by Organizations
3.2.2 Market Restraint Analysis
3.2.2.1 Lack of Access to Healthcare Data
3.3 Market Opportunity Analysis
3.3.1 Gap Between Research and Practice
3.4 Market Challenges Analysis
3.4.1 Issues with Rwe Validation, Operations, and Technologies
3.5 Real World Evidence (Rwe) Solutions: Market Analysis Tools
3.5.1 Industry Analysis - Porter’s
3.5.2 Industry Analysis - Pestle
3.6 Regulatory Framework
3.6.1 North America
3.6.2 Asia-Pacific
3.6.3 Europe - Regulatory Framework
3.7 Pricing Model Analysis
3.7.1 Pay Per Usage
3.7.2 Pay Per Patient Record
3.7.3 Annual/monthly Subscription
3.8 Case Study
3.8.1 Case Study 1:- OM1 Partnered with Healthcare Facilities to Collect Medical Data at a Clinical Level
3.8.2 Case Study 2:- Verana Health
Chapter 4 Real World Evidence (Rwe) Solutions: COVID-19 Impact
4.1 COVID-19 Disease Prevalence
4.2 Impact of COVID-19 on Market Players and Strategies Implemented
4.2.1 Ibm
4.2.2 Pharmaceutical Product Development (PPD)
4.2.3 Iqvia
4.3 Opportunity Analysis
Chapter 5 Real World Evidence Solutions Market: Component Analysis
5.1 Component Business Analysis
5.2 Real World Evidence Solutions Market: Component Movement Analysis
5.3 Services
5.3.1 Services Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4 Data Sets
5.4.1 Data Sets Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.2 Clinical Settings Data
5.4.2.1 Clinical Settings Data Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.3 Claims Data
5.4.3.1 Claims Data Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.4 Pharmacy Data
5.4.4.1 Pharmacy Data Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.5 Patient-powered Data
5.4.5.1 Patient-powered Data Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6 Real World Evidence Solutions Market: Application Analysis
6.1 Application Business Analysis
6.2 Real World Evidence Solutions Market: Application Movement Analysis
6.3 Drug Development & Approvals
6.3.1 Drug Development & Approvals Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4 Medical Device Development & Approvals
6.4.1 Medical Device Development & Approvals Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5 Reimbursement/coverage & Regulatory Decision-making
6.5.1 Reimbursement/coverage & Regulatory Decision-making Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6 Post-market Safety & Adverse Events Monitoring
6.6.1 Post-market Safety & Adverse Events Monitoring Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7 Real World Evidence Solutions Market: End Use Analysis
7.1 End Use Business Analysis
7.2 Real World Evidence Solutions Market: End Use Movement Analysis
7.3 Healthcare Companies
7.3.1 Healthcare Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
7.3.2 Clinical Research Market Estimates and Forecasts, 2018-2030 (USD Million)
7.3.3 Commercial Market Estimates and Forecasts, 2018-2030 (USD Million)
7.3.4 Heor Market Estimates and Forecasts, 2018-2030 (USD Million)
7.3.5 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4 Healthcare Payers
7.4.1 Healthcare Payers Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5 Healthcare Providers
7.5.1 Healthcare Providers Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6 Others
7.6.1 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8 Real World Evidence Solutions Market: Therapeutic Area Analysis
8.1 Therapeutic Area Business Analysis
8.2 Real World Evidence Solutions Market: Therapeutic Area Movement Analysis
8.3 Oncology
8.3.1 Oncology Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4 Cardiology
8.4.1 Cardiology Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5 Neurology
8.5.1 Neurology Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6 Diabetes
8.6.1 Diabetes Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7 Psychiatry
8.7.1 Psychiatry Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8 Respiratory
8.8.1 Respiratory Market Estimates and Forecasts, 2018-2030 (USD Million)
8.9 Other Therapeutic Areas
8.9.1 Other Therapeutic Areas Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 9 Real World Evidence (Rwe) Solutions Market: Regional Market Analysis, by Component, Application, Therapeutic Area, and End Use 2018-2030 (USD Million)
9.1 Regional Market Share Analysis, 2023 & 2030
9.2 Regional Market Snapshot
9.3 Regional Market Snapshot
9.4 North America
9.4.1 North America Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.2 U.S.
9.4.2.1 Country Dynamics
9.4.2.2 U.S. Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.3 Canada
9.4.3.1 Country Dynamics
9.4.3.2 Canada Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5 Europe
9.5.1 Europe Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.2 Germany
9.5.2.1 Country Dynamics
9.5.2.2 Germany Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.3 France
9.5.3.1 Country Dynamics
9.5.3.2 France Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.4 Uk
9.5.4.1 Country Dynamics
9.5.4.2 Uk Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.5 Italy
9.5.5.1 Country Dynamics
9.5.5.2 Italy Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.6 Spain
9.5.6.1 Country Dynamics
9.5.6.2 Spain Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.7 Denmark
9.5.7.1 Country Dynamics
9.5.7.2 Denmark Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.8 Sweden
9.5.8.1 Country Dynamics
9.5.8.2 Sweden Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.9 Norway
9.5.9.1 Country Dynamics
9.5.9.2 Norway Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.10 Asia-Pacific Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.11 Japan
9.5.11.1 Country Dynamics
9.5.11.2 Japan Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.12 China
9.5.12.1 Country Dynamics
9.5.12.2 China Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.13 India
9.5.13.1 Country Dynamics
9.5.13.2 India Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.14 Australia
9.5.14.1 Country Dynamics
9.5.14.2 Australia Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.15 South Korea
9.5.15.1 Country Dynamics
9.5.15.2 South Korea Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.16 Thailand
9.5.16.1 Country Dynamics
9.5.16.2 Thailand Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6 Latin America
9.6.1 Latin America Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.2 Brazil
9.6.2.1 Country Dynamics
9.6.2.2 Brazil Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.3 Mexico
9.6.3.1 Country Dynamics
9.6.3.2 Mexico Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.4 Argentina
9.6.4.1 Country Dynamics
9.6.4.2 Argentina Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.7 Mea
9.7.1 Mea Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.7.2 South Africa
9.7.2.1 Country Dynamics
9.7.2.2 South Africa Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.7.3 Saudi Arabia
9.7.3.1 Country Dynamics
9.7.3.2 Saudi Arabia Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.7.4 Israel
9.7.4.1 Country Dynamics
9.7.4.2 Israel Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.7.5 Uae
9.7.5.1 Country Dynamics
9.7.5.2 Uae Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
9.7.6 Kuwait
9.7.6.1 Country Dynamics
9.7.6.2 Kuwait Real World Evidence Solutions Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 10 Competitive Analysis
10.1 Market Participation Categorization
10.2 Strategic Mapping
10.3 Public Companies
10.3.1 Heat Map Analysis
10.4 Private Companies
Chapter 11 Company Profiles
11.1 IQVIA Inc.
11.1.1 Company Overview
11.1.2 Financial Performance
11.1.3 Product Benchmarking
11.1.4 Strategic Initiatives
11.2 IBM
11.2.1 Company Overview
11.2.2 Financial Performance
11.2.3 Product Benchmarking
11.2.4 Strategic Initiatives
11.3 PPD, Inc. (Acquired by Thermo Fisher Scientific, Inc.)
11.3.1 Company Overview
11.3.2 Financial Performance
11.3.3 Product Benchmarking
11.3.4 Strategic Initiatives
11.4 Parexel International (MA) Corporation
11.4.1 Company Overview
11.4.2 Financial Performance
11.4.3 Product Benchmarking
11.4.4 Strategic Initiatives
11.5 PerkinElmer Inc.
11.5.1 Company Overview
11.5.2 Financial Performance
11.5.3 Product Benchmarking
11.5.4 Strategic Initiatives
11.6 ICON Plc
11.6.1 Company Overview
11.6.2 Financial Performance
11.6.3 Product Benchmarking
11.6.4 Strategic Initiatives
11.7 Oracle
11.7.1 Company Overview
11.7.2 Financial Performance
11.7.3 Product Benchmarking
11.7.4 Strategic Initiatives
11.8 Syneos Health
11.8.1 Company Overview
11.8.2 Financial Performance
11.8.3 Product Benchmarking
11.8.4 Strategic Initiatives
11.9 Cegedim Health Data
11.9.1 Company Overview
11.9.2 Financial Performance
11.9.3 Product Benchmarking
11.9.4 Strategic Initiatives
11.10 Medpace
11.10.1 Company Overview
11.10.2 Financial Performance
11.10.3 Product Benchmarking
11.10.4 Strategic Initiatives
Chapter 12 Strategic Recommendation and Insights
12.1 Overview
12.2 Insights
12.3 Recommendation
List of Tables
Table 1 List of Abbreviation
Table 2 North America Real World Evidence Solutions Market, by Region, 2018-2030 (USD Million)
Table 3 North America Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 4 North America Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 5 North America Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 6 North America Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 7 U.S. Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 8 U.S. Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 9 U.S. Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 10 U.S. Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 11 Canada Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 12 Canada Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 13 Canada Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 14 Canada Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 15 Europe Real World Evidence Solutions Market, by Region, 2018-2030 (USD Million)
Table 16 Europe Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 17 Europe Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 18 Europe Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 19 Europe Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 20 Germany Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 21 Germany Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 22 Germany Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 23 Germany Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 24 UK Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 25 UK Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 26 UK Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 27 UK Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 28 France Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 29 France Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 30 France Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 31 France Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 32 Italy Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 33 Italy Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 34 Italy Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 35 Italy Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 36 Spain Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 37 Spain Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 38 Spain Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 39 Spain Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 40 Denmark Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 41 Denmark Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 42 Denmark Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 43 Denmark Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 44 Sweden Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 45 Sweden Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 46 Sweden Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 47 Sweden Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 48 Norway Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 49 Norway Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 50 Norway Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 51 Norway Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 52 Asia-Pacific Real World Evidence Solutions Market, by Region, 2018-2030 (USD Million)
Table 53 Asia-Pacific Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 54 Asia-Pacific Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 55 Asia-Pacific Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 56 Asia-Pacific Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 57 China Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 58 China Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 59 China Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 60 China Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 61 Japan Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 62 Japan Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 63 Japan Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 64 Japan Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 65 India Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 66 India Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 67 India Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 68 India Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 69 South Korea Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 70 South Korea Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 71 South Korea Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 72 South Korea Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 73 Australia Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 74 Australia Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 75 Australia Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 76 Australia Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 77 Thailand Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 78 Thailand Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 79 Thailand Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 80 Thailand Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 81 Latin America Real World Evidence Solutions Market, by Region, 2018-2030 (USD Million)
Table 82 Latin America Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 83 Latin America Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 84 Latin America Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 85 Latin America Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 86 Brazil Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 87 Brazil Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 88 Brazil Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 89 Brazil Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 90 Mexico Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 91 Mexico Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 92 Mexico Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 93 Mexico Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 94 Argentina Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 95 Argentina Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 96 Argentina Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 97 Argentina Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 98 MEA Real World Evidence Solutions Market, by Region, 2018-2030 (USD Million)
Table 99 MEA Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 100 MEA Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 101 MEA Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 102 MEA Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 103 South Africa Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 104 South Africa Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 105 South Africa Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 106 South Africa Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 107 Saudi Arabia Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 108 Saudi Arabia Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 109 Saudi Arabia Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 110 Saudi Arabia Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 111 Israel Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 112 Israel Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 113 Israel Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 114 Israel Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 115 UAE Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 116 UAE Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 117 UAE Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 118 UAE Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 119 Kuwait Real World Evidence Solutions Market, by Component, 2018-2030 (USD Million)
Table 120 Kuwait Real World Evidence Solutions Market, by Application, 2018-2030 (USD Million)
Table 121 Kuwait Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
Table 122 Kuwait Real World Evidence Solutions Market, by End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market Segmentation
Figure 2 Market Research Process
Figure 3 Data Triangulation Techniques
Figure 4 Primary Research Pattern
Figure 5 Market Research Approaches
Figure 6 Value-chain-based Sizing & Forecasting
Figure 7 QFD Modeling for Market Share Assessment
Figure 8 Market Formulation & Validation
Figure 9 Commodity Flow Analysis
Figure 10 Ancillary Market Outlook
Figure 11 Market Trends & Outlook
Figure 12 Market Driver Relevance Analysis (Current & Future Impact)
Figure 13 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 14 Real World Evidence Solutions Market: PORTER’s Five Forces Analysis
Figure 15 Real World Evidence Solutions Market: PESTEL Analysis
Figure 16 Real World Evidence Solutions Market Component Outlook: Key Takeaways
Figure 17 Real World Evidence Solutions Market: Component Movement Analysis
Figure 18 Services Market, 2018-2030 (USD Million)
Figure 19 Data Sets Market, 2018-2030 (USD Million)
Figure 20 Clinical Settings Data Market, 2018-2030 (USD Million)
Figure 21 Claims Data Market, 2018-2030 (USD Million)
Figure 22 Pharmacy Market, 2018-2030 (USD Million)
Figure 23 Patient-powered Data Market, 2018-2030 (USD Million)
Figure 24 Real World Evidence Solutions Market Application Outlook: Key Takeaways
Figure 25 Real World Evidence Solutions Market: Application Movement Analysis
Figure 26 Drug Development & Approvals Market, 2018-2030 (USD Million)
Figure 27 Medical Device Development & Approvals Market, 2018-2030 (USD Million)
Figure 28 Reimbursement/coverage & Regulatory Decision-making Market, 2018-2030 (USD Million)
Figure 29 Post-market Safety & Adverse Events Monitoring Market, 2018-2030 (USD Million)
Figure 30 Real World Evidence Solutions Market End-use Outlook: Key Takeaways
Figure 31 Real World Evidence Solutions Market: End Use Movement Analysis
Figure 32 Healthcare Companies Market, 2018-2030 (USD Million)
Figure 33 Clinical Research Market, 2018-2030 (USD Million)
Figure 34 Commercial Research Market, 2018-2030 (USD Million)
Figure 35 HEOR Market, 2018-2030 (USD Million)
Figure 36 Others Market, 2018-2030 (USD Million)
Figure 37 Healthcare Payers Market, 2018-2030 (USD Million)
Figure 38 Healthcare Providers Market, 2018-2030 (USD Million)
Figure 39 Others Market, 2018-2030 (USD Million)
Figure 40 Real World Evidence Solutions Market Therapeutic Area Outlook: Key Takeaways
Figure 41 Real World Evidence Solutions Market: Therapeutic Area Movement Analysis
Figure 42 Oncology Market, 2018-2030 (USD Million)
Figure 43 Cardiology Market, 2018-2030 (USD Million)
Figure 44 Neurology Market, 2018-2030 (USD Million)
Figure 45 Diabetes Market, 2018-2030 (USD Million)
Figure 46 Psychiatry Market, 2018-2030 (USD Million)
Figure 47 Respiratory Market, 2018-2030 (USD Million)
Figure 48 Other Therapeutic Areas Market, 2018-2030 (USD Million)
Figure 49 Regional Outlook, 2023 & 2030
Figure 50 Regional Marketplace: Key Takeaways
Figure 51 Regional Marketplace: Key Takeaways
Figure 52 North America Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 53 U.S Country Dynamics
Figure 54 U.S. Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 55 Canada Country Dynamics
Figure 56 Canada Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 57 Europe Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 58 Germany Country Dynamics
Figure 59 Germany Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 60 France Country Dynamics
Figure 61 France Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 62 UK Country Dynamics
Figure 63 UK Real Rorld Evidence Solutions Market, 2018-2030 (USD Million)
Figure 64 Italy Country Dynamics
Figure 65 Italy Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 66 Spain Country Dynamics
Figure 67 Spain Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 68 Denmark Country Dynamics
Figure 69 Denmark Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 70 Sweden Country Dynamics
Figure 71 Sweden Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 72 Norway Country Dynamics
Figure 73 Norway Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 74 Asia-Pacific Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 75 Japan Country Dynamics
Figure 76 Japan Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 77 China Country Dynamics
Figure 78 China Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 79 India Country Dynamics
Figure 80 India Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 81 Australia Country Dynamics
Figure 82 Australia Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 83 South Korea Country Dynamics
Figure 84 South Korea Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 85 Thailand Country Dynamics
Figure 86 Thailand Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 87 Latin America Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 88 Brazil Country Dynamics
Figure 89 Brazil Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 90 Mexico Country Dynamics
Figure 91 Mexico Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 92 Argentina Country Dynamics
Figure 93 Argentina Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 94 MEA Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 95 South Africa Country Dynamics
Figure 96 South Africa Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 97 Saudi Arabia Country Dynamics
Figure 98 Saudi Arabia Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 99 Israel Country Dynamics
Figure 100 Israel Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 101 UAE Country Dynamics
Figure 102 UAE Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 103 Kuwait Country Dynamics
Figure 104 Kuwait Real World Evidence Solutions Market, 2018-2030 (USD Million)
Figure 105 Market Participant Categorization
Figure 106 Real World Evidence Solutions Market: Strategy Mapping
Figure 107 Real World Evidence Solutions: Heat Map Analysis
Figure 108 Case Studies of RWE Impact Across Opportunity Areas

Companies Mentioned

  • IQVIA Inc.
  • IBM
  • PPD, Inc. (Acquired by Thermo Fisher Scientific, Inc.)
  • Parexel International (MA) Corporation
  • PerkinElmer Inc.
  • ICON plc
  • Oracle
  • Syneos Health
  • Cegedim Health Data
  • Medpace

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedMay 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 2.6 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.6 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Real World Evidence Solution Market by Component, Therapeutic Area, End-User - Global Forecast 2025-2030 - Product Image

Real World Evidence Solution Market by Component, Therapeutic Area, End-User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Real World Evidence Solutions Market by Component (Services, Disparate Data Sets (Clinical), Application (Drug and Medical Device Development and Approvals), Mode of Deployment, Revenue Model, End-users, & Region, Business Model - Forecast to 2029 - Product Image

Real World Evidence Solutions Market by Component (Services, Disparate Data Sets (Clinical), Application (Drug and Medical Device Development and Approvals), Mode of Deployment, Revenue Model, End-users, & Region, Business Model - Forecast to 2029

  • Report
  • 412 Pages
  • Global
From
Real-world Evidence Solutions Market Size, Share, Forecast, & Trends Analysis by Component Application, and End User - Global Forecast to 2031 - Product Image

Real-world Evidence Solutions Market Size, Share, Forecast, & Trends Analysis by Component Application, and End User - Global Forecast to 2031

  • Report
  • 254 Pages
  • Global
From
Real-World Evidence Solutions Market Report by Component, Therapeutic Area, End User, and Region 2024-2032 - Product Image

Real-World Evidence Solutions Market Report by Component, Therapeutic Area, End User, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From
Real World Evidence Solutions - Global Strategic Business Report - Product Image

Real World Evidence Solutions - Global Strategic Business Report

  • Report
  • 246 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.